TD Cowen on Pfizer (PFE): 'MFN Agreement an Important Positive'

October 1, 2025 8:08 AM EDT Send to a Friend
TD Cowen analyst Steve Scala reiterated a Hold rating and $30.00 price target on Pfizer (NYSE: PFE).The analyst commented: "MFN ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login